London Stock Exchange welcomes Ecofin U.S. Renewables Infrastructure Trust plc to the Main Market

Ecofin U.S. Renewables Infrastructure Trust plc (the "Company”) is pleased to announce that it has raised gross proceeds of $125 million pursuant to its initial public offering.

The Company intends to execute its investment objective by investing in a diversified portfolio of Renewable Assets predominantly in the United States, but it may also invest up to 15% of Gross Assets in other OECD countries. Sectors eligible for investment by the Company will include renewable energy (solar, wind, battery storage, biomass, hydroelectric and microgrids), water and waste-water and related Renewable Assets sectors, with a predominant focus on solar and wind.

The Company will seek to invest primarily through privately-negotiated middle market acquisitions of long-life Renewable Assets which are construction-ready, in-construction and/or currently in operation with long-term power purchase agreements or comparable contracts with investment-grade quality counterparties, including utilities, municipalities, universities, schools, hospitals, foundations, corporations and others.

Patrick O'D Bourke, Chairman of Ecofin U.S. Renewables Infrastructure Trust PLC, commented on the IPO:

 "We thank investors for their support for the Company and its investment mandate in this important asset class. We look forward to welcoming them as new shareholders, and to working with Ecofin Advisors to pursue the Company's investment objective."

 Jerry Polacek, Managing Director and Group Lead of Private Clean Energy and Infrastructure at Ecofin, said:

 "On behalf of Ecofin, I wish to thank every investor that made RNEW's offering possible against the backdrop of a global pandemic and a roadshow executed through a novel virtual format. Your support serves to directly expand investment in renewable energy and decarbonisation of the US power grid.  RNEW is well positioned to participate in the accelerating growth of US renewable energy derived from compelling economics for energy consumers and an improving national policy environment. The Ecofin team is working diligently to meet our commitments in order that RNEW can meet its investment objectives."
 

Quick facts

Track
Market: Main Market
Instrument market cap (£m)
-
Listing/Admission to trading
22 Dec 2020
Looking for new and recent issues?

More recent

82.16
London Stock Exchange welcomes Draper Esprit plc to the Main Market

Draper Esprit, a leading venture capital firm investing in and developing high growth digital technology businesses, today announces that it has moved its listings from London’s AIM and Dublin’s Euronext Growth Market to their respective main market partners. Its shares will today begin trading on the Premium Segment of London’s Main Market with a secondary listing on Euronext Dublin. 

Learn more
90.72
London Stock Exchange welcomes Zenova Group Plc to AIM

London Stock Exchange welcomes Zenova Group Plc to AIM in order to facilitate its plan to introduce its innovative cutting edge technologically driven products.

Zenova has developed a set of new fire safety and temperature management products that address the most pressing problems in this sector in a very efficient and cost effective way.
These comprise fire retardant pai

Learn more
London Stock Exchange welcomes Rize ETF celebrating the launch of its new ETF targeting environmental sustainability

London, UK – 23 July 2021 – Rize UCITS ICAV (“Rize ETF”), Europe’s first specialist thematic ETF issuer, has today unveiled a brand new ETF targeting environmental sustainability. The Rize Environmental Impact 100 UCITS ETF (LIFE) is the first ETF of its kind in Europe, and is available to buy from today on London Stock Exchange trading under the tickers LIFE (USD) and LVNG (GBP). In addition t

Learn more
London Stock Exchange welcomes GENincode plc to AIM

London Stock Exchange today welcomes GENinCode plc (“GENinCode” or the “Company” with the LSE-AIM ticker “GENI”), the cardiovascular disease (“CVD”) risk assessment company focused on predictive genetics for the prevention of cardiovascular disease. The Company is incorporated in England and Wales with its UK headquarters in Oxford. 

The Company has successfully raised £17 millio

Learn more